Physician profile
Kyle Douglas Parish
NPI 1881622751
$9,664.12
in general payments reported to CMS, 2019-2025
43 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 92% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $1,290 · 2021: $1,576 · 2022: $1,555 · 2023: $1,377 · 2024: $1,514 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,335.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,339.74 | 2021-2025 | |
| Amgen INC. | $1,047.96 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,046.21 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $1,036.59 | 2019-2025 | |
| Lilly USA, LLC | $576.09 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $521.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $431.56 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $382.52 | 2019-2024 | Trintellix |
| Sanofi-Aventis U.S. LLC | $375.47 | 2020-2023 | |
| Corium, LLC | $331.77 | 2021-2025 | Azstarys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.77 | 2019-2025 | Jardiance |
| Axsome Therapeutics, INC. | $235.81 | 2024-2025 | Auvelity, Symbravo |
| Allergan, INC. | $227.08 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $195.54 | 2019-2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $172.98 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Parish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.